185 related articles for article (PubMed ID: 37044126)
1. Case-Control Study of Long COVID, Sapporo, Japan.
Asakura T; Kimura T; Kurotori I; Kenichi K; Hori M; Hosogawa M; Saijo M; Nakanishi K; Iso H; Tamakoshi A
Emerg Infect Dis; 2023 May; 29(5):956-966. PubMed ID: 37044126
[TBL] [Abstract][Full Text] [Related]
2. Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study.
Fjelltveit EB; Blomberg B; Kuwelker K; Zhou F; Onyango TB; Brokstad KA; Elyanow R; Kaplan IM; Tøndel C; Mohn KGI; Özgümüş T; Cox RJ; Langeland N;
Clin Infect Dis; 2023 Feb; 76(3):e60-e70. PubMed ID: 35959897
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of and Risk Factors for Post-COVID-19 Condition during Omicron BA.5-Dominant Wave, Japan.
Iba A; Hosozawa M; Hori M; Muto Y; Muraki I; Masuda R; Tamiya N; Iso H
Emerg Infect Dis; 2024 Jul; 30(7):1380-1389. PubMed ID: 38916571
[TBL] [Abstract][Full Text] [Related]
4. The importance of anosmia, ageusia and age in community presentation of symptomatic and asymptomatic SARS-CoV-2 infection in Louisiana, USA; a cross-sectional prevalence study.
Feehan AK; Fort D; Velasco C; Burton JH; Garcia-Diaz J; Price-Haywood EG; Sapp E; Pevey D; Seoane L
Clin Microbiol Infect; 2021 Apr; 27(4):633.e9-633.e16. PubMed ID: 33421576
[TBL] [Abstract][Full Text] [Related]
5. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study.
Kikkenborg Berg S; Dam Nielsen S; Nygaard U; Bundgaard H; Palm P; Rotvig C; Vinggaard Christensen A
Lancet Child Adolesc Health; 2022 Apr; 6(4):240-248. PubMed ID: 35143771
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors of post-coronavirus disease 2019 condition among children and adolescents in Japan: A matched case-control study in the general population.
Hosozawa M; Hori M; Hayama-Terada M; Arisa I; Muto Y; Kitamura A; Takayama Y; Iso H
Int J Infect Dis; 2024 Jun; 143():107008. PubMed ID: 38484930
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.
Alkodaymi MS; Omrani OA; Fawzy NA; Shaar BA; Almamlouk R; Riaz M; Obeidat M; Obeidat Y; Gerberi D; Taha RM; Kashour Z; Kashour T; Berbari EF; Alkattan K; Tleyjeh IM
Clin Microbiol Infect; 2022 May; 28(5):657-666. PubMed ID: 35124265
[TBL] [Abstract][Full Text] [Related]
8. Investigation on the Factors Associated with the Persistence of Anosmia and Ageusia in Saudi COVID-19 Patients.
Algahtani SN; Alzarroug AF; Alghamdi HK; Algahtani HK; Alsywina NB; Bin Abdulrahman KA
Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162068
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychiatric symptoms in post-COVID-19 long haulers.
Alghamdi HY; Alrashed AM; Jawhari AM; Abdel-Moneim AS
Acta Neuropsychiatr; 2022 Dec; 34(6):318-329. PubMed ID: 35543105
[TBL] [Abstract][Full Text] [Related]
10. Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.
Fernández-de-Las-Peñas C; Rodríguez-Jiménez J; Cancela-Cilleruelo I; Guerrero-Peral A; Martín-Guerrero JD; García-Azorín D; Cornejo-Mazzuchelli A; Hernández-Barrera V; Pellicer-Valero OJ
JAMA Netw Open; 2022 Nov; 5(11):e2242106. PubMed ID: 36378309
[TBL] [Abstract][Full Text] [Related]
11. A statewide population-based approach to examining Long COVID symptom prevalence and predictors in Michigan.
Hirschtick JL; Xie Y; Slocum E; Hirschtick RE; Power LE; Elliott MR; Orellana RC; Fleischer NL
Prev Med; 2023 Dec; 177():107752. PubMed ID: 37944672
[TBL] [Abstract][Full Text] [Related]
12. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.
Rogers JP; Chesney E; Oliver D; Pollak TA; McGuire P; Fusar-Poli P; Zandi MS; Lewis G; David AS
Lancet Psychiatry; 2020 Jul; 7(7):611-627. PubMed ID: 32437679
[TBL] [Abstract][Full Text] [Related]
13. Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol.
Mera-Cordero F; Bonet-Monne S; Almeda-Ortega J; García-Sangenís A; Cunillera-Puèrtolas O; Contreras-Martos S; Alvarez-Muñoz G; Monfà R; Balanzo-Joué M; Morros R; Salvador-Gonzalez B
Trials; 2022 Jan; 23(1):19. PubMed ID: 34991703
[TBL] [Abstract][Full Text] [Related]
14. [Frequency, spectrum and risk factors of long COVID].
Pink I; Welte T
Inn Med (Heidelb); 2022 Aug; 63(8):813-818. PubMed ID: 35925071
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Messenger RNA Coronavirus Disease 2019 Vaccines Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Delta Variant Epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS).
Maeda H; Saito N; Igarashi A; Ishida M; Suami K; Yagiuchi A; Kimura Y; Komino M; Arai H; Morikawa T; Motohashi I; Miyazawa R; Moriyama T; Kamura H; Terada M; Kuwamitsu O; Hayakawa T; Sando E; Ohara Y; Teshigahara O; Suzuki M; Morimoto K
Clin Infect Dis; 2022 Nov; 75(11):1971-1979. PubMed ID: 35438137
[TBL] [Abstract][Full Text] [Related]
16. Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study.
Kikkenborg Berg S; Palm P; Nygaard U; Bundgaard H; Petersen MNS; Rosenkilde S; Thorsted AB; Ersbøll AK; Thygesen LC; Nielsen SD; Vinggaard Christensen A
Lancet Child Adolesc Health; 2022 Sep; 6(9):614-623. PubMed ID: 35752194
[TBL] [Abstract][Full Text] [Related]
17. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis.
Premraj L; Kannapadi NV; Briggs J; Seal SM; Battaglini D; Fanning J; Suen J; Robba C; Fraser J; Cho SM
J Neurol Sci; 2022 Mar; 434():120162. PubMed ID: 35121209
[TBL] [Abstract][Full Text] [Related]
18. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
[TBL] [Abstract][Full Text] [Related]
19. Post-acute COVID-19 condition in Saudi Arabia: A national representative study.
AlRadini FA; Alamri F; Aljahany MS; Almuzaini Y; Alsofayan Y; Khan A; Albogami N; Abdulrahim M; Almogbil A; Alahmari A
J Infect Public Health; 2022 May; 15(5):526-532. PubMed ID: 35429791
[TBL] [Abstract][Full Text] [Related]
20. Symptom profiles and their risk factors in patients with post-COVID-19 condition: a Dutch longitudinal cohort study.
van Zon SKR; Ballering AV; Brouwer S; Rosmalen JGM;
Eur J Public Health; 2023 Dec; 33(6):1163-1170. PubMed ID: 37608757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
